Clene Inc. Shares Outstanding (Cover Page)
Clene Inc. (CLNN) had Shares Outstanding (Cover Page) of 12.85 million shares as of 2026-08-11, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-11: Entity Common Stock, Shares Outstanding 12.85M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 12.78M shares.
- 2026-03-13: Entity Common Stock, Shares Outstanding 11.78M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 10.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 12.85M shares 10-Q · filed 2026-08-14 |
| 2026-05-11 | 12.78M shares 10-Q · filed 2026-05-14 |
| 2026-03-13 | 11.78M shares 10-K · filed 2026-03-17 |
| 2025-11-10 | 10.33M shares 10-Q · filed 2025-11-13 |
| 2025-08-11 | 9.99M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 8.98M shares 10-Q · filed 2025-05-07 |
| 2025-03-19 | 8.59M shares 10-K · filed 2025-03-24 |
| 2024-11-05 | 7.98M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 6.47M shares 10-Q · filed 2024-08-07 |
| 2024-05-06 | 128.43M shares 10-Q · filed 2024-05-08 |
| 2024-03-08 | 128.43M shares 10-K · filed 2024-03-13 |
| 2023-11-03 | 128.42M shares 10-Q · filed 2023-11-07 |
| 2023-08-10 | 128.40M shares 10-Q · filed 2023-08-14 |
| 2023-05-09 | 78.39M shares 10-Q · filed 2023-05-12 |
| 2023-03-09 | 76.93M shares 10-K · filed 2023-03-13 |
| 2022-11-02 | 73.82M shares 10-Q · filed 2022-11-07 |
| 2022-08-10 | 63.50M shares 10-Q · filed 2022-08-15 |
| 2022-05-04 | 63.26M shares 10-Q · filed 2022-05-09 |
| 2022-03-08 | 63.14M shares 10-K · filed 2022-03-11 |
| 2021-11-04 | 62.20M shares 10-Q · filed 2021-11-08 |
| 2021-08-06 | 61.49M shares 10-Q · filed 2021-08-09 |
| 2021-05-07 | 59.57M shares 10-Q · filed 2021-05-10 |
| 2021-03-25 | 59.53M shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |